HEALTH

WHO Approves First Monkeypox Vaccine with 76% Effectiveness After One Dose

The World Health Organization has officially approved the MVA-BN monkeypox vaccine, which shows up to 82% effectiveness. The vaccine will be given in two doses to individuals aged 18 and over.
2024-09-14
WHO Approves First Monkeypox Vaccine with 76% Effectiveness After One Dose

The World Health Organization (WHO) has approved the first monkeypox vaccine, MVA-BN. This vaccine is set to be administered in two doses to individuals aged 18 years and older, with a four-week interval between doses.

 

The newly approved vaccine has shown promising results in clinical trials. According to the WHO, the vaccine is 76% effective against the monkeypox virus after the first dose and increases to 82% effectiveness after receiving the second dose. This represents a critical step in combating the spread of monkeypox, which has been declared a public health emergency by the WHO.

 

The global situation surrounding monkeypox has been alarming. The virus has spread to 121 countries, with 500 reported deaths this year alone. The WHO highlights that monkeypox can have a high mortality rate of up to 10% in high-risk groups and individuals with compromised immune systems. This underscores the urgent need for effective preventive measures and vaccination.

 

In Pakistan, five cases of monkeypox have been reported, all linked to travelers from various countries. This underscores the importance of global vaccination efforts and surveillance to prevent further spread of the virus.

 

The approval of the MVA-BN vaccine is a crucial milestone in the fight against monkeypox. The WHO's endorsement of this vaccine is expected to enhance global vaccination campaigns and provide much-needed protection against the virus. The vaccine's introduction will be instrumental in controlling outbreaks and reducing the virus's impact on public health.

 

The WHO's declaration of monkeypox as a public health emergency reflects the seriousness of the situation and the need for international cooperation in addressing the virus. As vaccination efforts ramp up, the global community will be better equipped to manage and mitigate the effects of monkeypox.